|
1
|
Oliver AL: Lung cancer: Epidemiology and
screening. Surg Clin North Am. 102:335–344. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Passiglia F, Bertaglia V, Reale ML,
Delcuratolo MD, Tabbò F, Olmetto E, Capelletto E, Bironzo P and
Novello S: Major breakthroughs in lung cancer adjuvant treatment:
Looking beyond the horizon. Cancer Treat Rev. 101:1023082021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Passiglia F, Pilotto S, Facchinetti F,
Bertolaccini L, Del Re M, Ferrara R, Franchina T, Malapelle U,
Menis J, Passaro A, et al: Treatment of advanced non-small-cell
lung cancer: The 2019 AIOM (Italian Association of Medical
Oncology) clinical practice guidelines. Crit Rev Oncol Hematol.
146:1028582020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bakir B, Chiarella AM, Pitarresi JR and
Rustgi AK: EMT, MET, plasticity, and tumor metastasis. Trends Cell
Biol. 30:764–776. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O'Leary K, Shia A and Schmid P: Epigenetic
regulation of EMT in non-small cell lung cancer. Curr Cancer Drug
Targets. 18:89–96. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yuan X, Wu H, Han N, Xu H, Chu Q, Yu S,
Chen Y and Wu K: Notch signaling and EMT in non-small cell lung
cancer: Biological significance and therapeutic application. J
Hematol Oncol. 7:872014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mittal V: Epithelial mesenchymal
transition in tumor metastasis. Annu Rev Pathol. 13:395–412. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Geuens T, Bouhy D and Timmerman V: The
hnRNP family: Insights into their role in health and disease. Hum
Genet. 135:851–867. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han N, Li W and Zhang M: The function of
the RNA-binding protein hnRNP in cancer metastasis. J Cancer Res
Ther. 9 (Suppl):S129–S134. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou ZJ, Dai Z, Zhou SL, Hu ZQ, Chen Q,
Zhao YM, Shi YH, Gao Q, Wu WZ, Qiu SJ, et al: HNRNPAB induces
epithelial-mesenchymal transition and promotes metastasis of
hepatocellular carcinoma by transcriptionally activating SNAIL.
Cancer Res. 74:2750–2762. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Y, Chen Q, Piao HY, Wang B, Zhu GQ,
Chen EB, Xiao K, Zhou ZJ, Shi GM, Shi YH, et al: HNRNPAB-regulated
lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinoma.
Int J Cancer. 146:169–180. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao Y, Zhang W, Jin YT and Zou Q: Mining
the prognostic value of HNRNPAB and its function in breast
carcinoma. Int J Genomics. 2020:37506732020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pan T, Yu Z, Jin Z, Wu X, Wu A, Hou J,
Chang X, Fan Z, Li J, Yu B, et al: Tumor suppressor lnc-CTSLP4
inhibits EMT and metastasis of gastric cancer by attenuating
HNRNPAB-dependent Snail transcription. Mol Ther Nucleic Acids.
23:1288–1303. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen ZQ, Yuan T, Jiang H, Yang YY, Wang L,
Fu RM, Luo SQ, Zhang T, Wu ZY and Wen KM: MicroRNA-8063 targets
heterogeneous nuclear ribonucleoprotein AB to inhibit the
self-renewal of colorectal cancer stem cells via the Wnt/β-catenin
pathway. Oncol Rep. 46:2192021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang C, Yin C, Wang L, Zhang S, Qian Y,
Ma J, Zhang Z, Xu Y and Liu S: HSPC111 governs breast cancer growth
by regulating ribosomal biogenesis. Mol Cancer Res. 12:583–594.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Karimi Dermani F, Gholamzadeh Khoei S,
Afshar S and Amini R: The potential role of nucleophosmin (NPM1) in
the development of cancer. J Cell Physiol. 236:7832–7852. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu J, Lai Y, Huang H, Ramakrishnan S, Pan
Y, Ma VWS, Cheuk W, So GYK, He Q, Geoffrey Lau C, et al: TCOF1
upregulation in triple-negative breast cancer promotes stemness and
tumour growth and correlates with poor prognosis. Br J Cancer.
126:57–71. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu G, Shan T, He S, Ren M, Zhu M, Hu Y, Lu
X and Zhang D: Overexpression of CENP-H as a novel prognostic
biomarker for human hepatocellular carcinoma progression and
patient survival. Oncol Rep. 30:2238–2244. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He WL, Li YH, Yang DJ, Song W, Chen XL,
Liu FK, Wang Z, Li W, Chen W, Chen CY, et al: Combined evaluation
of centromere protein H and Ki-67 as prognostic biomarker for
patients with gastric carcinoma. Eur J Surg Oncol. 39:141–149.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu X, Lin Y, Shi L, Huang Y, Lai C, Wang
Y, Zhang M, Wang S, Heng B, Yu G, et al: Upregulation of centromere
protein H is associated with progression of renal cell carcinoma. J
Mol Histol. 46:377–385. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bao B, Yu X and Zheng W: MiR-139-5p
targeting CCNB1 modulates proliferation, migration, invasion and
cell cycle in lung adenocarcinoma. Mol Biotechnol. 64:852–860.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guan Y, Zhu X, Liang J, Wei M, Huang S and
Pan X: Upregulation of HSPA1A/HSPA1B/HSPA7 and downregulation of
HSPA9 were related to poor survival in colon cancer. Front Oncol.
11:7496732021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen L, Kang Y, Jiang Y, You J, Huang C,
Xu X and Chen F: Overexpression of SFXN1 indicates poor prognosis
and promotes tumor progression in lung adenocarcinoma. Pathol Res
Pract. 237:1540312022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen D, Zhao Z, Chen L, Li Q, Zou J and
Liu S: PPM1G promotes the progression of hepatocellular carcinoma
via phosphorylation regulation of alternative splicing protein
SRSF3. Cell Death Dis. 12:7222021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han GH, Yun H, Chung JY, Kim JH and Cho H:
TMED9 expression level as a biomarker of epithelial ovarian cancer
progression and prognosis. Cancer Genomics Proteomics. 19:692–702.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weinreb JT and Bowman TV: Clinical and
mechanistic insights into the roles of DDX41 in haematological
malignancies. FEBS Lett. 596:2736–2745. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wenk MR and Choi H: Abundant circulating
lipids-a new opportunity for NSCLC detection? Nat Rev Clin Oncol.
19:361–362. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie W, Zhu H, Zhao M, Wang L, Li S, Zhao
C, Zhou Y, Zhu B, Jiang X, Liu W and Ren C: Crucial roles of
different RNA-binding hnRNP proteins in Stem Cells. Int J Biol Sci.
17:807–817. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu J, Zhong C, Luo J, Shu F, Lv D, Liu Z,
Tan X, Wang S, Wu K, Yang T, et al: HnRNP-L-regulated
circCSPP1/miR-520h/EGR1 axis modulates autophagy and promotes
progression in prostate cancer. Mol Ther Nucleic Acids. 26:927–944.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Torosyan Y, Dobi A, Glasman M, Mezhevaya
K, Naga S, Huang W, Paweletz C, Leighton X, Pollard HB and
Srivastava M: Role of multi-hnRNP nuclear complex in regulation of
tumor suppressor ANXA7 in prostate cancer cells. Oncogene.
29:2457–2466. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu Y, Wang X, Gu Q, Wang J, Sui Y, Wu J
and Feng J: Heterogeneous nuclear ribonucleoprotein A/B: An
emerging group of cancer biomarkers and therapeutic targets. Cell
Death Discov. 8:3372022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fares J, Fares MY, Khachfe HH, Salhab HA
and Fares Y: Molecular principles of metastasis: A hallmark of
cancer revisited. Signal Transduct Target Ther. 5:282020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ostrowska-Podhorodecka Z and McCulloch CA:
Vimentin regulates the assembly and function of matrix adhesions.
Wound Repair Regen. 29:602–612. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang Y, Zhao B, Lv L, Yang Y, Li S and Wu
H: FBXL10 promotes EMT and metastasis of breast cancer cells via
regulating the acetylation and transcriptional activity of SNAI1.
Cell Death Discov. 7:3282021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
López-Moncada F, Torres MJ, Lavanderos B,
Cerda O, Castellón EA and Contreras HR: SPARC induces E-cadherin
repression and enhances cell migration through Integrin αvβ3 and
the transcription factor ZEB1 in prostate cancer cells. Int J Mol
Sci. 23:58742022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xiong Y, Lai X, Xiang W, Zhou J, Han J, Li
H, Deng H, Liu L, Peng J and Chen L: Galangin (GLN) suppresses
proliferation, migration, and invasion of human glioblastoma cells
by targeting Skp2-induced epithelial-mesenchymal transition (EMT).
Onco Targets Ther. 13:9235–9244. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li JL, Wang ZQ and Sun XL: MYL6B drives
the capabilities of proliferation, invasion, and migration in
rectal adenocarcinoma through the EMT process. Open Life Sci.
15:522–531. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu C, Xia D, Wang D, Wang S, Sun Z, Xu B
and Zhang D: TCOF1 coordinates oncogenic activation and rRNA
production and promotes tumorigenesis in HCC. Cancer Sci.
113:553–564. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li
MZ, Shi L, Zeng MS and Song LB: Centromere protein H is a novel
prognostic marker for human nonsmall cell lung cancer progression
and overall patient survival. Cancer. 115:1507–1517. 2009.
View Article : Google Scholar : PubMed/NCBI
|
